Clinical Trial Update: Emtricitabine for Prevention of Vertical Transmission of HBV in Chinese Pregnant HBsAg Positive Patients [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating emtricitabine for preventing vertical transmission of chronic hepatitis B in HBsAg-positive pregnant patients in China.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Emtricitabine (Emtricitabine)

Snippet

Sponsor: Asian-Pacific Alliance of Liver Disease, Beijing | Conditions: Hepatitis B, Chronic, Pregnancy | Phase 4 | Status: UNKNOWN